NET PROFIT (x1000 DKK)
EMPLOYEES
Biocell AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
533
|
1
|
1,340 |
| Earnings before taxes |
-488
|
71
|
797 |
| EBITDA |
-509
|
-481
|
-443 |
| Total assets |
9,065
|
9,654
|
10,404 |
| Current assets |
2,776
|
5,440
|
7,238 |
| Current liabilities |
1,270
|
1,300
|
1,981 |
| Equity capital |
7,795
|
8,354
|
8,423 |
| - share capital |
649
|
672
|
668 |
| Employees (average) |
1
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
86.0%
|
86.5%
|
81.0% |
| Turnover per employee | 0 | ||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
0.5%
|
0.7%
|
20.5% |
| Current ratio |
218.6%
|
418.5%
|
365.4% |
| Return on equity (ROE) |
-6.3%
|
0.8%
|
9.5% |
| Change turnover |
0
|
0
|
-25,591 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
1
|
0
|
-1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.